Guangdong Xinghao Pharmaceutical

Guangdong Xinghao Pharmaceutical is a high-tech pharmaceutical enterprise and a core subsidiary of Beijing Xinghao Pharmaceutical, based in Zhongshan, China. The company specializes in the research, development, and large-scale production of high-end generic drugs and innovative formulations, with a particular emphasis on complex injectables. It operates a robust CMC and CMO/CDMO service platform that provides integrated drug development and manufacturing solutions to global and domestic partners. Guangdong Xinghao's therapeutic focus includes oncology, cardiovascular diseases, gastroenterology, and neurology. The company utilizes advanced drug delivery technologies, such as its proprietary Solu-B platform, to enhance the solubility and stability of pharmaceutical products. Its facilities are GMP-certified and equipped for various dosage forms, including lyophilized powders and solid oral preparations.